Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Chlamydia trachomatis is the most common sexually transmitted human pathogen. Infection results in minimal to no symptoms in approximately two-thirds of women and therefore often goes undiagnosed. C. trachomatis infections are a major public health concern because of the potential severe long-term consequences, including an increased risk of ectopic pregnancy, chronic pelvic pain, and infertility. To date, several point-of-care tests have been developed for C. trachomatis diagnostics. Although many of them are fast and specific, they lack the required sensitivity for large-scale application. We describe a rapid and sensitive form of detection directly from urine samples. The assay uses recombinase polymerase amplification and has a minimum detection limit of 5 to 12 pathogens per test. Furthermore, it enables detection within 20 minutes directly from urine samples without DNA purification before the amplification reaction. Initial analysis of the assay from clinical patient samples had a specificity of 100% (95% CI, 92%-100%) and a sensitivity of 83% (95% CI, 51%-97%). The whole procedure is fairly simple and does not require specific machinery, making it potentially applicable in point-of-care settings.

Original publication




Journal article


J Mol Diagn

Publication Date





127 - 135


Chlamydia Infections, Chlamydia trachomatis, DNA, Bacterial, DNA-Directed DNA Polymerase, Diacylglycerol Cholinephosphotransferase, Female, Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating), Humans, Molecular Diagnostic Techniques, Nucleic Acid Amplification Techniques, Polymerase Chain Reaction, Recombinases, Sensitivity and Specificity, Sexually Transmitted Diseases, Bacterial